C79.62 Secondary malignant neoplasm of left ovary

Name of the Condition

• Secondary Malignant Neoplasm of Left Ovary
• ICD-10 Code: C79.62

Summary

Secondary malignant neoplasm of the left ovary refers to cancer that has metastasized to the left ovary from a primary tumor located elsewhere in the body. This condition indicates the spread of an existing malignancy to the ovarian tissue and requires evaluation to identify the primary cancer source and guide management.

Causes

Secondary malignant neoplasms of the left ovary arise when cancer cells from a primary tumor detach, travel through the bloodstream or lymphatic system, and establish new tumors in the ovaries. Common primary sites include the breast, gastrointestinal tract, or other organs with high metastatic potential.

Risk Factors

• History of primary cancer, particularly those with known ovarian metastatic patterns (e.g., breast, colorectal).
• Advanced stage of the primary tumor.
• Lack of effective treatment for the primary cancer.
• Weakened immune system.
• Genetic predisposition to aggressive cancer types.

Symptoms

• Abdominal or pelvic pain.
• Bloating or swelling in the abdomen.
• Changes in bowel or urinary habits.
• Unexplained weight loss or fatigue.
• Vaginal bleeding (postmenopausal or irregular).
• Palpable abdominal mass.

Diagnosis

Imaging tests (CT, MRI, or PET scans) are used to detect metastatic lesions in the left ovary. Biopsy of ovarian tissue may be performed to confirm the diagnosis and identify the primary cancer source. Laboratory tests, including tumor markers, may also assist in evaluation.

Treatment Options

Treatment focuses on managing the primary cancer and addressing metastatic disease. Options may include systemic therapies (chemotherapy, targeted therapy), radiation, or surgery, depending on the primary tumor type and extent of spread. Multidisciplinary care is often recommended.

Prognosis and Follow-Up

Prognosis depends on the primary cancer type, stage, and response to treatment. Regular follow-up with imaging and clinical assessments is essential to monitor for recurrence or progression. Supportive care may be needed to manage symptoms and maintain quality of life.

Complications

• Obstruction of nearby organs (e.g., bowel, bladder).
• Ascites (fluid buildup in the abdomen).
• Pain or discomfort.
• Metastasis to other sites.
• Reduced ovarian function.

Lifestyle & Prevention

• Maintain a healthy lifestyle to support overall well-being during treatment.
• Follow recommended cancer screening guidelines for early detection of primary tumors.
• Discuss risk-reduction strategies with a healthcare provider if there is a history of cancer.

When to Seek Professional Help

Seek medical attention if experiencing persistent abdominal pain, unexplained weight loss, or other symptoms of metastatic disease. Prompt evaluation is important for timely diagnosis and management.

Tips for Medical Coders

Code C79.62 is specific to secondary malignant neoplasm of the left ovary. Documentation should specify the laterality (left) and confirm the metastatic nature of the neoplasm. Ensure the primary cancer site is documented separately if applicable. Follow coding guidelines for neoplasm metastasis and laterality.